Westfield Capital Management
BEAT

Westfield Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Westfield Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-50,100
Closed -$585K – 297
2016
Q1 		$585K Hold
50,100
– – ﹤0.01% 234
2015
Q4 		$585K Hold
50,100
– – ﹤0.01% 249
2015
Q3 		$613K Buy
+50,100
New +$639K ﹤0.01% 237

Other funds holding BEAT

CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Westfield Capital Management's BEAT Position: Q2 2016 in Review

Westfield Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q2 2016, closing a stake of 50,100 shares — an estimated $585K sold.

Westfield Capital Management first reported a position in BEAT in Q3 2015 and held it in 3 quarters. The position peaked at $613K in Q3 2015. 139 funds tracked by Wall St. Rank hold BEAT as of Q2 2016.

  • Westfield Capital Management reported no remaining BioTelemetry, Inc. position as of Q2 2016 after selling out during the quarter.
  • Westfield Capital Management sold 50,100 BioTelemetry, Inc. shares in Q2 2016, an estimated $585K.
  • Westfield Capital Management first reported a position in BioTelemetry, Inc. in Q3 2015 and held it in 3 quarters.
  • Westfield Capital Management's BioTelemetry, Inc. position peaked at $613K in Q3 2015.
  • 139 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2016.

Based on Westfield Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.